117 related articles for article (PubMed ID: 8867668)
1. Expression of an adenovirally encoded lymphotoxin-beta inhibitor prevents clearance of Listeria monocytogenes in mice.
Trüeb R; Brown G; Van Huffel C; Poltorak A; Valdez-Silva M; Beutler B
J Inflamm; 1995; 45(4):239-47. PubMed ID: 8867668
[TBL] [Abstract][Full Text] [Related]
2. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
Sacca R; Cuff CA; Lesslauer W; Ruddle NH
J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
[TBL] [Abstract][Full Text] [Related]
3. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice.
Mackay F; Majeau GR; Lawton P; Hochman PS; Browning JL
Eur J Immunol; 1997 Aug; 27(8):2033-42. PubMed ID: 9295042
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
Warzocha K; Bienvenu J; Coiffier B; Salles G
Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
[TBL] [Abstract][Full Text] [Related]
5. TNF and lymphotoxin beta cooperate in the maintenance of secondary lymphoid tissue microarchitecture but not in the development of lymph nodes.
Kuprash DV; Alimzhanov MB; Tumanov AV; Anderson AO; Pfeffer K; Nedospasov SA
J Immunol; 1999 Dec; 163(12):6575-80. PubMed ID: 10586051
[TBL] [Abstract][Full Text] [Related]
6. Lymphotoxin and LIGHT signaling pathways and target genes.
Schneider K; Potter KG; Ware CF
Immunol Rev; 2004 Dec; 202():49-66. PubMed ID: 15546385
[TBL] [Abstract][Full Text] [Related]
7. Independent protective effects for tumor necrosis factor and lymphotoxin alpha in the host response to Listeria monocytogenes infection.
Roach DR; Briscoe H; Saunders BM; Britton WJ
Infect Immun; 2005 Aug; 73(8):4787-92. PubMed ID: 16040991
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
9. Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting.
Matsumoto M
J Med Invest; 1999 Aug; 46(3-4):141-50. PubMed ID: 10687308
[TBL] [Abstract][Full Text] [Related]
10. Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells.
Prinz M; Montrasio F; Klein MA; Schwarz P; Priller J; Odermatt B; Pfeffer K; Aguzzi A
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):919-24. PubMed ID: 11792852
[TBL] [Abstract][Full Text] [Related]
11. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
[TBL] [Abstract][Full Text] [Related]
12. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization.
Rennert PD; Browning JL; Hochman PS
Int Immunol; 1997 Nov; 9(11):1627-39. PubMed ID: 9418124
[TBL] [Abstract][Full Text] [Related]
13. Mouse lymphotoxin-beta receptor. Molecular genetics, ligand binding, and expression.
Force WR; Walter BN; Hession C; Tizard R; Kozak CA; Browning JL; Ware CF
J Immunol; 1995 Dec; 155(11):5280-8. PubMed ID: 7594541
[TBL] [Abstract][Full Text] [Related]
14. Mice heterozygous for a deletion of the tumor necrosis factor-alpha and lymphotoxin-alpha genes: biological importance of a nonlinear response of tumor necrosis factor-alpha to gene dosage.
Amiot F; Boussadia O; Cases S; Fitting C; Lebastard M; Cavaillon JM; Milon G; Dautry F
Eur J Immunol; 1997 Apr; 27(4):1035-42. PubMed ID: 9130661
[TBL] [Abstract][Full Text] [Related]
15. Lymphotoxin-beta and TNF regulation in T cell subsets: differential effects of PGE2.
Ferreri NR; Millet I; Askari B; Magnani P; Ruddle NH
Cytokine; 1997 Mar; 9(3):157-65. PubMed ID: 9126704
[TBL] [Abstract][Full Text] [Related]
16. Expression of lymphotoxin-beta (LT-beta) in chronic inflammatory conditions.
Agyekum S; Church A; Sohail M; Krausz T; Van Noorden S; Polak J; Cohen J
J Pathol; 2003 Jan; 199(1):115-21. PubMed ID: 12474234
[TBL] [Abstract][Full Text] [Related]
17. Lymphotoxin alpha 1 beta 2: a critical mediator in V alpha 14i NKT cell differentiation.
Franki AS; Van Beneden K; Dewint P; Meeus I; Veys E; Deforce D; Elewaut D
Mol Immunol; 2005 Feb; 42(4):413-7. PubMed ID: 15607792
[TBL] [Abstract][Full Text] [Related]
18. Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.
Degli-Esposti MA; Davis-Smith T; Din WS; Smolak PJ; Goodwin RG; Smith CA
J Immunol; 1997 Feb; 158(4):1756-62. PubMed ID: 9029113
[TBL] [Abstract][Full Text] [Related]
19. Acetaminophen hepatotoxicity in tumor necrosis factor/lymphotoxin-alpha gene knockout mice.
Boess F; Bopst M; Althaus R; Polsky S; Cohen SD; Eugster HP; Boelsterli UA
Hepatology; 1998 Apr; 27(4):1021-9. PubMed ID: 9537442
[TBL] [Abstract][Full Text] [Related]
20. Membrane lymphotoxin contributes to anti-leishmanial immunity by controlling structural integrity of lymphoid organs.
Wilhelm P; Riminton DS; Ritter U; Lemckert FA; Scheidig C; Hoek R; Sedgwick JD; Körner H
Eur J Immunol; 2002 Jul; 32(7):1993-2003. PubMed ID: 12115620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
